SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trending following strong quarterly financial results and encouraging clinical data for its long-acting HAE treatment, Navenibart, presented at the American Academy of Allergy, Asthma & Immunology meeting. This news is igniting renewed community debate about its undervalued status and the possibility of a short squeeze amidst significant short interest.

Codatta

XNY (Codatta) is trending as it showcases remarkable price strength and green candles, defying broader crypto market downturns. The community is buzzing about its technical breakouts and potential for explosive growth, fueled by its utility in powering AI's data future.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE is gaining traction as its dedicated community actively buys dips, fueled by its unique origin as "Grok's dog" from xAI and recent positive catalysts like a new exchange listing and renewed influencer attention, reinforcing its "AI dog" memecoin narrative.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending following its approximately $7.8 billion acquisition of Arcellx, a strategic move to significantly expand its oncology portfolio with promising CAR-T cell therapy. This acquisition is generating considerable community discussion as a key step in diversifying beyond its strong HIV franchise and highlights ongoing M&A in the biotech space.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is generating significant buzz due to its high-performance EVM-compatible layer-1 blockchain and attractive staking rewards, leading the community to confidently accumulate and discuss its impressive resilience and recent ecosystem integrations amidst general market downturns.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is a top discussion point with the community actively anticipating a significant price surge driven by escalating Middle East tensions and potential oil supply disruptions, while a strong earnings beat and dividend hike further bolster bullish sentiment.

ProShares Trust - ProShares Bitcoin ETF

ProShares Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF ($BITO) is trending as a significantly reduced dividend payout and Bitcoin's price correction trigger community discussions around potential share price erosion and a reverse stock split, while many investors actively accumulate, anticipating a rebound.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as news of Meta's multi-billion dollar AI chip deal for Google's TPUs and the launch of upgraded Gemini AI models energizes the community, alongside a recent Wells Fargo upgrade. Investors are keenly watching its expanding AI infrastructure and Waymo's increasing market presence, positioning it as a strong competitor in the evolving AI landscape despite broader market jitters.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is a major talking point as escalating Middle East tensions, ignited by confirmed US-Israeli strikes that killed Iran's Supreme Leader and subsequent Iranian retaliation, fuel intense speculation among the community about surging oil prices and significant disruptions to global shipping through the Strait of Hormuz.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as discussions erupt over the reported death of Iran's Supreme Leader following U.S./Israel strikes; the community is sharply divided, with some celebrating a decisive move attributed to Trump's leadership, while others view it as a dangerous political distraction from the Epstein files with potential for wider global instability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) today announced that management will participate in the following upcoming investor conferences, which are being conducted...

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) will report its fourth quarter and full year 2025 financial results on Tuesday, March 3, 2026. Amylyxs senior management team will...

Patient Square Capital LP Takes Position in Amylyx Pharmaceuticals, Inc. $AMLX

Patient Square Capital LP bought a new stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with...

GSA Capital Partners LLP Sells 118,426 Shares of Amylyx Pharmaceuticals, Inc. $AMLX

GSA Capital Partners LLP lowered its position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 69.4% in the 3rd quarter, according to its most recent Form 13F filing with the...

Bank of America Forecasts Strong Price Appreciation for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock

Bank of America lifted their target price on shares of Amylyx Pharmaceuticals from $15.00 to $19.00 and gave the stock a "buy" rating in a research report on Friday...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Consensus Recommendation of "Moderate Buy" by Analysts

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the thirteen analysts that are presently covering the firm, MarketBeat Ratings...

Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million

Key PointsJoshua B Cohen sold 138,167 shares for a total transaction value of ~$1.9 million on Jan. 15 and Jan. 16, 2026, at a weighted average price of $13.59 per share...

HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE...

FY2030 Earnings Estimate for AMLX Issued By HC Wainwright

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) - Research analysts at HC Wainwright issued their FY2030 earnings per share (EPS) estimates for Amylyx Pharmaceuticals in a report issued on...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Recommendation of "Moderate Buy" by Analysts

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) has received an average recommendation of "Moderate Buy" from the thirteen brokerages that are currently covering the company, MarketBeat...

Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

AMLX
Amylyx Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AMLX News

AMLXAmylyx Pharmaceuticals Inc